Figure 5
Hepatic Pparα and Gapdh, mRNA and protein levels in human ApoA-I transgenic mice that were fed either control diet or fenofibrate-containing diet. (a) Northern blotting analysis of RNA isolated from the livers of control and fenofibrate-treated mice for Pparα and Gapdh expression. (b) Western blotting analysis showing hepatic protein for Pparα and Gapdh protein levels of control and fenofibrate-treated mice. (c) Bar graphs showing the ratio of Pparα/Gapdh levels of Pparα mRNA of mice fed a control or fenofibrate-containing diet as shown in panel a. (d) Hepatic Esrrg mRNA levels of human ApoA-I transgenic mice treated with either control diet or fenofibrate-containing diet.
